Iovance Biotherapeutics (IOVA) Institutional Ownership $7.81 -0.03 (-0.38%) (As of 12/17/2024 05:56 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Iovance Biotherapeutics (NASDAQ:IOVA)CurrentInstitutional OwnershipPercentage77.03%Number ofInstitutional Buyers(last 12 months)116TotalInstitutional Inflows(last 12 months)$349.55MNumber ofInstitutional Sellers(last 12 months)62TotalInstitutional Outflows(last 12 months)$119.87M Get IOVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IOVA Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Iovance Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.100,229$979K0.0%+9.2%0.033% 11/21/2024 SkyView Investment Advisors LLC20,000$188K0.0%N/A0.007% 11/18/2024 Arete Wealth Advisors LLC34,600$325K0.0%-45.4%0.011% 11/16/2024 Geode Capital Management LLC5,648,995$53.05M0.0%-2.4%1.853% 11/15/2024 Barclays PLC604,584$5.68M0.0%+118.8%0.198% 11/15/2024 Wellington Management Group LLP129,482$1.22M0.0%+10.3%0.042% Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp13,201,978$123.97M0.0%+4.6%4.332% 11/15/2024 Stifel Financial Corp223,107$2.10M0.0%+35.8%0.073% 11/15/2024 NFJ Investment Group LLC189,655$1.78M0.1%-4.4%0.062% 11/15/2024 Centiva Capital LP16,625$156K0.0%N/A0.005% 11/15/2024 Erste Asset Management GmbH34,000$327K0.0%N/A0.011% 11/14/2024 PFM Health Sciences LP132,152$1.24M0.1%-13.5%0.043% 11/14/2024 Portland Investment Counsel Inc.40,000$376K0.1%+33.3%0.013% 11/14/2024 Braidwell LP217,928$2.05M0.1%-85.1%0.072% 11/14/2024 Verition Fund Management LLC23,679$222K0.0%N/A0.008% 11/14/2024 Captrust Financial Advisors49,606$466K0.0%+95.0%0.016% 11/14/2024 Walleye Capital LLC13,665$128K0.0%-45.6%0.004% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,946,842$18.28M0.0%-2.4%0.639% 11/13/2024 BNP Paribas Financial Markets113,724$1.07M0.0%-75.5%0.037% 11/13/2024 FMR LLC82,662$776K0.0%+79.2%0.027% 11/13/2024 The Manufacturers Life Insurance Company311,907$2.93M0.0%-7.0%0.102% 11/13/2024 DRW Securities LLC12,854$121K0.0%N/A0.004% 11/12/2024 Pekin Hardy Strauss Inc.33,050$310K0.0%-5.7%0.012% 11/12/2024 Algert Global LLC54,070$508K0.0%+53.2%0.019% 11/12/2024 Eagle Asset Management Inc.1,356,779$12.74M0.1%-30.0%0.485% 11/12/2024 Charles Schwab Investment Management Inc.1,913,144$17.96M0.0%-3.6%0.684% 11/9/2024 Landscape Capital Management L.L.C.65,525$615K0.1%N/A0.023% 11/9/2024 Intech Investment Management LLC97,958$920K0.0%N/A0.035% 11/8/2024 Grandfield & Dodd LLC30,070$282K0.0%N/A0.011% 11/7/2024 LMR Partners LLP41,211$387K0.0%-32.7%0.015% 11/7/2024 Quest Partners LLC2,819$26K0.0%-43.7%0.001% 11/6/2024 Curi RMB Capital LLC108,637$1.02M0.0%+49.8%0.039% 11/6/2024 Pier 88 Investment Partners LLC44,180$415K0.1%-24.6%0.016% 11/6/2024 Saturna Capital Corp20,553$193K0.0%+7.0%0.007% 11/5/2024 Victory Capital Management Inc.144,280$1.36M0.0%+399.4%0.052% 11/5/2024 GSA Capital Partners LLP25,824$242K0.0%N/A0.009% 11/4/2024 Los Angeles Capital Management LLC61,759$580K0.0%+156.0%0.022% 11/2/2024 XML Financial LLC14,500$136K0.0%+7.4%0.005% 11/1/2024 Assetmark Inc.12,853$121K0.0%+48.0%0.005% 10/31/2024 Principal Financial Group Inc.4,033,184$37.87M0.0%+59.0%1.441% Could this be the hottest crypto discovery of all time? (Ad)I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here10/30/2024 Beacon Financial Advisory LLC21,120$198K0.1%+42.7%0.008% 10/29/2024 Farther Finance Advisors LLC15,389$145K0.0%+142.3%0.005% 10/28/2024 Creative Financial Designs Inc. ADV21,740$204K0.0%+59.3%0.008% 10/28/2024 Rice Hall James & Associates LLC1,679,157$15.77M0.9%+2.6%0.600% 10/28/2024 US Bancorp DE19,655$185K0.0%-30.9%0.007% 10/25/2024 China Universal Asset Management Co. Ltd.58,376$548K0.1%+77.6%0.021% 10/24/2024 Clear Harbor Asset Management LLC17,550$165K0.0%-43.0%0.006% 10/23/2024 Mirae Asset Global Investments Co. Ltd.10,978$105K0.0%+31.4%0.004% 10/23/2024 Hennion & Walsh Asset Management Inc.351,449$3.30M0.2%-4.5%0.126% 10/22/2024 Bank Pictet & Cie Europe AG19,368$182K0.0%-54.9%0.007% 10/16/2024 nVerses Capital LLC15,800$148K0.1%N/A0.006% 10/16/2024 Vontobel Holding Ltd.18,940$178K0.0%+32.5%0.007% 10/16/2024 SeaCrest Wealth Management LLC20,406$192K0.0%-5.9%0.007% 10/11/2024 Creative Planning73,489$690K0.0%+2.6%0.026% 10/11/2024 ORG Wealth Partners LLC9,432$89K0.0%N/A0.003% 10/10/2024 Shaker Investments LLC OH100,712$946K0.4%+27.7%0.036% 10/10/2024 Exchange Traded Concepts LLC17,071$160K0.0%+11.6%0.006% 10/8/2024 Brookstone Capital Management20,055$188K0.0%+43.9%0.007% 10/5/2024 Handelsbanken Fonder AB74,800$702K0.0%+18.2%0.027% 8/19/2024 B. Riley Wealth Advisors Inc.13,296$107K0.0%N/A0.005% 8/16/2024 Perceptive Advisors LLC25,933,142$207.98M4.9%+34.6%9.267% 8/16/2024 Creative Planning71,593$574K0.0%-7.1%0.026% 8/16/2024 Algert Global LLC35,286$283K0.0%-9.0%0.013% 8/16/2024 Cim Investment Management Inc.31,172$250K0.1%+126.3%0.011% 8/15/2024 Long Focus Capital Management LLC4,132,000$33.14M1.3%+195.1%1.477% 8/15/2024 The Manufacturers Life Insurance Company335,513$2.69M0.0%-6.5%0.120% 8/15/2024 Dark Forest Capital Management LP44,858$360K0.1%N/A0.016% 8/15/2024 AQR Capital Management LLC11,477$92K0.0%-71.3%0.004% 8/14/2024 Squarepoint Ops LLC257,543$2.07M0.0%N/A0.092% 8/14/2024 Marshall Wace LLP1,612,055$12.93M0.0%N/A0.576% 8/14/2024 Xponance Inc.16,279$131K0.0%+13.0%0.006% 8/14/2024 Magnetar Financial LLC82,363$661K0.0%N/A0.029% 8/14/2024 Hood River Capital Management LLC2,732,427$21.91M0.5%+4.1%0.976% 8/14/2024 EverSource Wealth Advisors LLC6,609$58K0.0%N/A0.002% 8/14/2024 ProShare Advisors LLC49,061$393K0.0%-21.1%0.018% 8/14/2024 Profund Advisors LLC124,660$1M0.0%+33.1%0.045% 8/13/2024 Ensign Peak Advisors Inc74,592$598K0.0%+13.4%0.027% 8/13/2024 Sei Investments Co.284,761$2.28M0.0%-14.5%0.102% 8/12/2024 Seven Eight Capital LP77,240$619K0.1%-55.7%0.028% 8/12/2024 Vanguard Personalized Indexing Management LLC22,085$177K0.0%+27.2%0.008% 8/12/2024 E Fund Management Co. Ltd.40,912$328K0.0%+48.2%0.015% 8/10/2024 Virtu Financial LLC94,099$755K0.1%N/A0.034% 8/9/2024 Edgestream Partners L.P.99,605$799K0.0%N/A0.036% 8/9/2024 Pekin Hardy Strauss Inc.35,050$281K0.0%-18.6%0.013% 8/9/2024 Dimensional Fund Advisors LP2,265,555$18.17M0.0%-21.1%0.810% 8/8/2024 Wealthspire Advisors LLC57,000$457K0.0%N/A0.020% 8/8/2024 Parametrica Management Ltd261,090$2.09M2.8%+98.4%0.093% 8/8/2024 American Century Companies Inc.203,038$1.63M0.0%-40.0%0.073% 8/8/2024 Rice Hall James & Associates LLC1,636,025$13.12M0.8%-4.5%0.585% 8/7/2024 Headlands Technologies LLC16,067$129K0.0%N/A0.006% Could this be the hottest crypto discovery of all time? (Ad)I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here8/7/2024 Daiwa Securities Group Inc.8,813$71K0.0%+754.0%0.003% 8/7/2024 Choreo LLC14,354$116K0.0%N/A0.005% 8/6/2024 Quest Partners LLC5,003$40K0.0%+1,237.7%0.002% 8/6/2024 Pier 88 Investment Partners LLC58,580$470K0.1%+155.8%0.021% 8/6/2024 Los Angeles Capital Management LLC24,124$193K0.0%N/A0.009% 8/6/2024 Candriam S.C.A.500,033$4.01M0.0%-52.8%0.179% 8/5/2024 Arizona State Retirement System54,734$439K0.0%+3.8%0.020% 8/3/2024 TD Asset Management Inc284,878$2.29M0.0%-43.6%0.102% 8/1/2024 Rhumbline Advisers368,800$2.96M0.0%-5.8%0.132% 7/31/2024 Abacus Planning Group Inc.10,284$82K0.0%N/A0.004% (Data available from 1/1/2016 forward) IOVA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOVA shares? During the previous two years, 217 institutional investors and hedge funds held shares of Iovance Biotherapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($369.25M), Perceptive Advisors LLC ($207.98M), Avoro Capital Advisors LLC ($173.39M), State Street Corp ($123.97M), Price T Rowe Associates Inc. MD ($78.07M), Geode Capital Management LLC ($53.05M), and Artisan Partners Limited Partnership ($39.25M).Learn more on IOVA's institutional investors. What percentage of Iovance Biotherapeutics stock is owned by institutional investors? 77.03% of Iovance Biotherapeutics stock is owned by institutional investors. Learn more on IOVA's institutional investor holdings. Which institutional investors have been buying Iovance Biotherapeutics stock? Of the 184 institutional investors that purchased Iovance Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($6.68M), Avoro Capital Advisors LLC ($5M), Vanguard Group Inc. ($4.52M), Principal Financial Group Inc. ($3.68M), Long Focus Capital Management LLC ($2.73M), Renaissance Technologies LLC ($2.39M), and Artisan Partners Limited Partnership ($2.30M). How much institutional buying is happening at Iovance Biotherapeutics? Institutional investors have bought a total of 57,470,243 shares in the last 24 months. This purchase volume represents approximately $484.95M in transactions. Which Iovance Biotherapeutics major shareholders have been selling company stock? Of the 94 institutional investors that sold Iovance Biotherapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deutsche Bank AG ($2.81M), Boxer Capital LLC ($2.74M), Avoro Capital Advisors LLC ($2M), Franklin Resources Inc. ($1.88M), ARK Investment Management LLC ($1.54M), Perceptive Advisors LLC ($1.30M), and Braidwell LP ($1.25M). How much institutional selling is happening at Iovance Biotherapeutics? Institutional investors have sold a total of 27,508,290 shares in the last 24 months. This volume of shares sold represents approximately $210.22M in transactions. Related Companies Intra-Cellular Therapies Institutional Ownership Roivant Sciences Institutional Ownership Ascendis Pharma A/S Institutional Ownership Revolution Medicines Institutional Ownership Lantheus Institutional Ownership Legend Biotech Institutional Ownership Nuvalent Institutional Ownership Blueprint Medicines Institutional Ownership Elanco Animal Health Institutional Ownership Cytokinetics Institutional Ownership This page (NASDAQ:IOVA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOVA Stock Alerts